Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited has announced an update regarding its ongoing on-market buy-back program. As of September 19, 2025, the company has repurchased a total of 206,953 ordinary fully paid securities, with an additional 460 securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the production and distribution of a range of health supplements and pharmaceutical products. The company targets markets that emphasize health-conscious living and preventive healthcare.
Average Trading Volume: 12,715
Technical Sentiment Signal: Buy
Current Market Cap: A$138.6M
See more insights into VLS stock on TipRanks’ Stock Analysis page.